Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001171843-23-007223

Chief Operating Officer gave up 64,415 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bisker-Leib Vered Chief Operating Officer 2023-11-17 Shares withheld for taxes −64,415 $1.50 $96,623 1,420,499 D
Loading xslF345X05/ownership.xml…